In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...

Dr. David A. Braun delved into the molecular factors which drive exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.

For instance, a study on colorectal cancer liver metastasis utilized single-cell ... into tissue-specific gene expression and the clonal distribution of immune cells across different tissues ...